The World Health Organization (WHO) declared the novel coronavirus disease 2019 (COVID-19) a public health emergency of international concern on January 30, 2020 and by March 11, 2020, the WHO officially classified it as a pandemic. [@OR200363-1] [@OR200363-2] New York City quickly became the epicenter of the COVID-19 pandemic, prompting the New York State governor to declare a disaster emergency and sign an executive order limiting gatherings and closing businesses. [@OR200363-3] For obstetric patients receiving prenatal care in the greater New York City area, attending in-person prenatal care visits, including travel to and from appointments and interaction with health care personnel and staff, represented an additional potential source of exposure.

Telehealth in the form of video visits represents one approach to mitigating risk of viral exposure for patients and providers, and has been proposed as a mean of ensuring continued care in the setting of disasters. [@JR200363-4] [@JR200363-5] For a variety of medical specialties, telehealth may represent a means of maintaining patient care access in the setting of COVID-19 while facilitating physical distancing and lightening the burden of clinical practice settings. [@JR200363-5] Prior research on integration of telehealth into the health care system has been conducted in rural communities and has demonstrated both challenges and opportunities for improved care. [@JR200363-6] [@JR200363-7]

Given that many other locales in the United States may be faced with similar challenges related to the COVID-19 pandemic and that COVID-19 may recur seasonally, or some other disaster may require similar changes to health care delivery, the purpose of this study was to review adoption of telehealth for obstetric patients in a tertiary referral hospital and clinic system in New York City.

Materials and Methods
=====================

Columbia University Irving Medical Center (CUIMC)-affiliated obstetric ambulatory prenatal care facilities located in midtown Manhattan, Washington Heights in Upper Manhattan, Rockland County, and Westchester transitioned to telehealth for prenatal care during the COVID-19 outbreak in the greater New York City metropolitan area. These facilities provide care for patients with both Medicaid and commercial insurance. Patients accessing prenatal care at these sites deliver primarily at NewYork Presbyterian Morgan Stanley Children\'s Hospital of New York, a tertiary referral center performing approximately 4,600 deliveries per year, and NewYork Presbyterian/The Allen Hospital, a community hospital performing approximately 2,300 deliveries per year. This study was approved by the Columbia University Irving Medical Center review board (AAAS9987).

Telehealth was incorporated into prenatal care at an accelerated rate beginning from March 16, 2020, shortly after schools, bars, and restaurants in New York City were ordered to close. Video visits were performed with Epic Haiku and Canto with patients accessing care via the Epic Connect and MyChart application on their phones or other portable devices (Epic, Verona, WI). Providers were trained in this software the week prior to adoption via a short video tutorial course (∼15 minutes in duration) and user guide with additional support as needed. Patients were guided through installation of software by staff either by in-person visit, by e-mailed instructions, and/or remotely by telephone guidance.

To understand the degree to which telehealth was utilized in the setting of the COVID-19 pandemic, we examined the proportion of attended prenatal care visits that were able to be performed remotely over a 5-week period from March 9, 2020 to April 12, 2020, during which time telehealth was adopted across clinical sites. This study period included 1 week of preimplementation data. We evaluated prenatal visits for the following three types of practices providing prenatal care: (1) a generalist obstetrics and gynecology faculty practice providing care to patients with commercial insurance in Midtown Manhattan, Upper Manhattan, and Rockland County; (2) a maternal-fetal medicine (MFM) obstetrics and gynecology faculty practice providing care to patients with commercial insurance in Midtown Manhattan, Upper Manhattan, and Westchester; and (3) a clinic system in Upper Manhattan providing prenatal care to a population with Medicaid insurance primarily residing in Upper Manhattan and the Bronx which consolidated to a single site during the pandemic. The proportion of prenatal care visits performed by telehealth each week was determined. Additionally, whether visits were performed by telehealth was further analyzed based on whether visits were (1) a first prenatal care visit, (2) a return prenatal care visit, (3) a postpartum visit, (4) a consultation during pregnancy, or (5) a preconception consultation. In addition to the three practices, consultations for genetic counseling were also evaluated. Finally, the number of no-show visits was analyzed during this time period by practice, based on whether visits were scheduled to be held in-person or via telehealth. In rare cases where telehealth visits were conducted by telephone and not video because a technical failure occurred, these visits were categorized as telehealth visits. Categorical comparisons were performed with the Chi-square test or Fisher\'s exact test as appropriate with the Cochran--Armitage test for trend used to compare the proportion of telehealth visits by week. All statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC.).

In addition to the quantitative analysis of telehealth visits, a survey of providers routinely providing prenatal care was performed. Providers were also invited to perform a related semistructured interview. Investigators contacted potential respondents by e-mail to present the study and solicit their voluntary participation in the 3- to 5-minute survey and a related 10- to 15-minute interview. All providers who conducted telehealth visits during the implementation period were eligible to participate in both the survey and interviews. The survey consisted of a demographic and background questionnaire followed by a two-part set of questions designed to ascertain provider experience and satisfaction with the integration of telehealth. Part one of the survey comprised a series of statements to which each provider noted their agreement on a 5-point Likert\'s scale. Part two consisted of a short series of multiple-choice questions designed to better understand specifics surrounding the process of operationalization of telehealth. The survey was developed and housed electronically in the REDCap database. To further characterize the impact of telehealth uptake on our Medicaid population, we performed a sensitivity analysis looking at the survey results and perceptions among health clinic providers only.

For the interview portion, participants were informed about the purpose of the study and verbal consent was obtained to perform, record, and transcribe the interview prior to beginning. Each individual was asked a series of open-ended questions regarding their specific experiences with integration of telehealth into their practice. The recordings were transcribed, deidentified, and stored in the REDCap database. Providers who were operations leaders in both the MFM and generalist faculty practices and health clinics were additionally queried regarding telehealth transition and uptake. Given the COVID-19 pandemic, most interviews were conducted using Zoom meetings with the Voice Memos application when conducted in person. Each interview record was transcribed verbatim and reviewed by a group of three authors (S.O., U.E., and N.M.) for accuracy. The qualitative data were evaluated using a framework approach with thematic analysis. [@JR200363-8] The transcribed interview responses were used to generate broad categories. Three investigators (S.O., U.E., and N.M.) assessed the responses for divergence and convergence, weighting each theme by assessing the frequency of it being mentioned.

Results
=======

During the study period, there were 4,248 pregnancy-related ambulatory visits of which 950 (22.4%) were to generalists, 980 (23.1%) were to MFM providers, and 2,318 (54.6%) were to clinics ( [Table 1](#TB200363-1){ref-type="table"} ). Approximately one-third of visits were performed by telehealth during the study period ( *n*  = 1,352, 31.8%). For genetic counseling appointments, two-thirds of visits took place via telehealth (96/143, 67.1%). Over the study period, the proportion of telehealth visits increased significantly for each practice ( *p*  \< 0.01 for all based on the Cochran--Armitage test for trend). By the fifth week, 56.1% of visits in the generalist faculty practice, 61.5% of visits in the MFM faculty practice, 41.5% of health clinic visits, and 100% of genetic counseling visits were performed via telehealth ( [Fig. 1](#FI200363-1){ref-type="fig"} ); the increased use of telehealth in the generalist and MFM faculty practices compared with the clinics was statistically significant ( *p*  \< 0.01 based on the Cochran--Armitage test for trend). Analyzing telehealth utilization by visit type, by the last week of the study period postpartum visits were most likely to be performed via telehealth (87.3%), followed by return prenatal visits (47.8%), and new prenatal visits (29.3%; [Fig. 2](#FI200363-2){ref-type="fig"} ). Analyzing visit types by practice in the last week of the study period, MFM was significantly more likely to perform new prenatal visits (81.3%) by telehealth compared with generalists (35.3%) and the health clinics (18.1%; *p*  \< 0.01; [Figs. 3A--C](#FI200363-3){ref-type="fig"} ). For return prenatal visits during the final week of the study, 53.6% were performed via telehealth for the MFM faculty practice compared with 58.0% for the generalist faculty practice, and 41.6% for clinics ( *p*  \< 0.01). For postpartum visits at the final week of the study, 85.7% were performed via telehealth at health clinics, 96.7% at the MFM faculty practice, and 57.1% at the faculty generalist practice ( *p*  \< 0.01). Evaluating appointment no-shows, at no point in the study period were no-show rates above 10% for the generalist or MFM faculty practices for either in-person or telehealth visits. In comparison, for the health clinics 24.1% of visits were no-shows in week 1, rising to 47.4% in week 3, and then decreasing to 25.8% in week 5 ( [Fig. 4A--C](#FI200363-4){ref-type="fig"} ). The proportion of no-show appointments for telehealth versus inpatient visits was similar at health clinic appointments weeks 3 through 5.

###### Outpatient obstetric visits by week by practice type by visit type during the COVID-19 pandemic

  Practice                                     Generalist obstetricians   Maternal-fetal medicine   Health clinics                                                         
  -------------------------------------------- -------------------------- ------------------------- ---------------- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  Attended visits                                                                                                                                                          
   All attended scheduled visits               227                        168                       180              177   198   190   156   163   237   234   520   442   304
   Telehealth visits                           0                          23                        82               97    111   4     43    96    152   144   0     62    101
   All preconception consultations             1                          4                         2                0     6     2     1     0                             
   Telehealth preconception consultations      0                          1                         4                2     0     1     0                                   
   All return OB prenatal visits               181                        136                       154              151   174   148   133   118   180   179   390   350   249
   Telehealth return OB prenatal visits        0                          17                        67               81    101   1     35    65    107   96    0     48    85
   All new OB prenatal visits                  24                         19                        9                12    17    14    13    28    33    16    92    65    37
   Telehealth new OB prenatal visits           0                          2                         3                6     0     6     19    25    13    0     2     4     8
   All consultations during pregnancy          0                          5                         3                6     3     8     0                                   
   Telehealth consultations during pregnancy   0                          4                         2                5     0                                               
   All postpartum visits                       21                         12                        13               12    7     17    5     10    20    30    37    27    18
   Telehealth postpartum visits                0                          5                         9                11    4     3     1     7     17    29    0     12    27
  No-show visits                                                                                                                                                           
   All no-shows                                5                          10                        9                7     6     2     3     6     9     17    165   186   274
   Telehealth no-shows                         0                          2                         6                4     2     0     6     9     14    0     10    114   109

Abbreviations: COVID-19. Novel coronavirus disease 2019; OB, obstetric.

Note: Number of visits by week for each of three practices is demonstrated: (1) generalist obstetrician gynecologists, (2) maternal-fetal medicine specialists, and (3) health clinics providing care to a primarily Medicaid population staffed by generalists, maternal-fetal medicine specialists, nurse practitioners, and nurse midwives.

![Proportion of scheduled visits conducted by telehealth by practice group by week during the COVID-19 pandemic. The figure demonstrates the proportion of outpatient obstetrical visits conducted by telehealth for generalist obstetrician gynecologists, maternal-fetal medicine specialists, health clinics, and genetic counselors by week over a 5-week period from March 9, 2020 through April 12, 2020.](10-1055-s-0040-1712939-i200363-1){#FI200363-1}

![Proportion of scheduled visits conducted by telehealth by week by type of visit during the COVID-19 pandemic. The figure demonstrates the proportion of outpatient obstetrical visits conducted by telehealth for new prenatal care visits, return prenatal care visits, and postpartum visits by week over a 5-week period from March 9, 2020 through April 12, 2020. COVID-19, novel coronavirus 2019; OB, obstetrician.](10-1055-s-0040-1712939-i200363-2){#FI200363-2}

![( **A** ) Proportion of scheduled visits conducted by telehealth at health clinics by week by type of visit. ( **B** ) Proportion of scheduled visits conducted by telehealth by MFM providers by week by type of visit. ( **C** ) Proportion of scheduled visits conducted by telehealth by generalist obstetrician-gynecologists by week by type of visit. The figure demonstrates the proportion of outpatient obstetrical visits conducted by telehealth for each type of obstetrical visit by week over a five week period from March 9, 2020 through April 12, 2020 individually for health clinics ( **A** ) primarily serving patients with public insurance and MFM ( **B** ) and generalist ( **C** ) practices primarily serving patients with commercial insurance. MFM, maternal-fetal medicine; OB, obstetrician.](10-1055-s-0040-1712939-i200363-3){#FI200363-3}

![( **A** ) Proportion of visits that were no-shows for telehealth versus in-person visits at health centers by week. ( **B** ) Proportion of visits that were no-shows for telehealth versus in-person visits at generalist practices by week. ( **C** ) Proportion of visits that were no-shows for telehealth versus in-person visits at MFM practices be week. The figure demonstrates the proportion of outpatient obstetrical visits scheduled for telehealth visits and in-person visits that were no-shows by week from March 9, 2020 through April 12, 2020 for health center visits ( **A** ), generalist practices ( **B** ), and MFM practices ( **C** ). MFM, maternal-fetal medicine.](10-1055-s-0040-1712939-i200363-4){#FI200363-4}

For the survey, 36 of 68 queried (53%) providers caring for prenatal patients provided survey information. The majority of respondents were physicians ( *n*  = 30, 83.3%), half of whom ( *n*  = 18) were attending physicians, and a quarter of whom were MFM fellows or attendings ( [Supplementary Table S1](#SM200363-1){ref-type="supplementary-material"} , available in the online version). Overall, 97% of respondents believed telehealth increased access for patients and 92% believed that telehealth provided adequate care when appropriately scheduled ( [Fig. 5](#FI200363-5){ref-type="fig"} ).The majority of providers believed telehealth was convenient both for their patients and for their practice. While only 45% of providers were motivated to use telehealth prior to the pandemic, 89% would continue using the technology in the future. The majority of providers (80%) said that telehealth technology was easy to set up and 56% felt support was adequate during transition ( [Fig. 6](#FI200363-6){ref-type="fig"} ). Minorities of providers felt they experienced significant challenges during implementation (6%) that they spent significant time on implementation (3%), or that they needed significant technological support (14%). In comparing video (and rare telephone) visits to in-person visits, pluralities or majorities of providers stated that video visits did not change preparation time (50%), documentation time (56%), ease of results of follow-up (69%), patient rapport (53%), billing difficulties (39%), or patient safety (47%; [Fig. 7](#FI200363-7){ref-type="fig"} ). Providers were more likely to think that efficiency increased (42%) than decreased (31%) and that time of visit decreased (50%) compared with increased (19.4%) with telehealth. In evaluating barriers to care, the most common obstacle cited by providers (78% of respondents) was patient difficulty in accessing and using technology. Resources cited by providers as helpful in telehealth integration included administrative support staff (including members of the hospital information technology (IT) help center, Epic electronic medical record (EMR) help personnel, and volunteer staff; 67%), departmental support (including modules and training videos provided by the department, provision of office space specifically suitable for telehealth, provision of mobile devices to staff whose devices were not compatible; 67%), and support from IT (47%). When the data were restricted to health clinic providers ( *n*  = 23), results were similar to the primary analysis ( [Supplementary Figs. 1](#SM200363-1){ref-type="supplementary-material"} [2](#SM200363-1){ref-type="supplementary-material"} [3](#SM200363-1){ref-type="supplementary-material"} , available in the online version).

![Prenatal provider attitudes toward telehealth. This figure demonstrates provider degree of agreement with seven survey statements designed to evaluate attitudes and beliefs to toward the use of telehealth in clinical practice on a 5-point Likert\'s scale. COVID-19. Novel coronavirus disease 2019.](10-1055-s-0040-1712939-i200363-5){#FI200363-5}

![Prenatal provider experience with telehealth implementation. This figure demonstrates provider degree of agreement with five survey statements designed to evaluate practitioner experience with the telehealth implementation process on a 5-point Likert\'s scale.](10-1055-s-0040-1712939-i200363-6){#FI200363-6}

![Prenatal provider perceptions of characteristics of telehealth compared with in-person visits. This figure demonstrates provider perceptions about how telehealth has changed various visit metrics as compared with in-person visits.](10-1055-s-0040-1712939-i200363-7){#FI200363-7}

In performing interviews with 11 of 36 survey respondents (of whom 12 were invited for interviews), several key themes arose ( [Table 2](#TB200363-2){ref-type="table"} ). Providers noted that patient benefits of telehealth included decreased COVID-19 exposure, that patients could continue to access care in the setting of stay-at-home instructions, and there were telehealth benefits for patients with increased childcare responsibilities. Telehealth was facilitated by patients having easy access to required technology and devices. Perceived barriers for patients attending health clinics included the following: (1) hesitation or anxiety in using telehealth, (2) difficulty in setting up software, and (3) accessing continuous Wi-Fi or data for the visit. In interviews, providers noted that integrating telehealth was facilitated by access to colleagues with telehealth experience, the ease of use of the technology, online modules and work flow documents for using the telehealth software and interface, and easy access to EMR data to plan visits in advance. A barrier to use noted by providers was that interpreter services were more cumbersome during telehealth visits. Departmental factors noted to facilitate care included guideline templates for prenatal care appointments and fetal testing and ultrasound indications.

###### Qualitative survey findings on the use of telehealth for prenatal care based on provider interviews

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                  Benefits of telehealth                                                                                       Facilitators of telehealth                                                                             Barriers to telehealth
  --------------- ------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------
  Patient         • Limits COVID-19 exposure\                                                                                  • Concerns of COVID-19 exposure\                                                                       • Discomfort/hesitation/anxiety with telehealth visits and technology [a](#FN200363-4){ref-type="table-fn"}\
                  • Ensures continued access to care\                                                                          • Appreciation of continued care\                                                                      • Initial set-up technically difficult [a](#FN200363-4){ref-type="table-fn"}\
                  • Convenience for patients with increased childcare responsibilities [a](#FN200363-4){ref-type="table-fn"}   • Access to required technology and devices (i.e., smart phones, tablet, e-mail)                       • Technical difficulties with logging on and maintaining continuous Wi-Fi or data connection through visit [a](#FN200363-4){ref-type="table-fn"}\
                                                                                                                                                                                                                                      • Need for home monitoring devices (i.e., fetal heart tone Doppler\'s, blood pressure cuffs)

  Provider        • Limits COVID-19 exposure\                                                                                  • Access to colleagues with prior telehealth experience\                                               • Limited data on the use of telehealth in routine obstetrics\
                  • Ensures continued access to care                                                                           • Ease of use of telehealth technology\                                                                • Technical difficulties with logging on\
                                                                                                                               • Online modules/work-flow documents on how to use telehealth software and interface\                  • Language barriers/translation services more difficult to use during telehealth visits [a](#FN200363-4){ref-type="table-fn"}
                                                                                                                               • Accessible EMR data to plan telehealth care encounters in advance of visit                           

  Clinic/Office   • Limits COVID-19 exposure                                                                                   • Protection of patients and staff\                                                                    • Rapidity of integration\
                                                                                                                               • Online modules for support staff\                                                                    • Recent transition to EMR/unfamiliarity with telehealth administration and scheduling\
                                                                                                                               • Assistance for office staff in telehealth scheduling and administration\                             • Lack of up-to-date patient contact information [a](#FN200363-4){ref-type="table-fn"}\
                                                                                                                               • Centralized patient call center to facilitate patient technological troubleshooting and scheduling   • Additional support staff required numbers [a](#FN200363-4){ref-type="table-fn"}\
                                                                                                                                                                                                                                      • Challenges with patient scheduling [a](#FN200363-4){ref-type="table-fn"}

  Departmental                                                                                                                 • Development of guidelines regarding which antenatal visits are appropriate for telehealth\           • Rapid implementation precluded small scale testing\
                                                                                                                               • Development of guidelines regarding frequency and interval of ultrasound monitoring                  • Compliance/billing issues
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: COVID-19. Novel coronavirus disease 2019; OB, obstetric; EMR, electronic medical record.

Noted by providers to be more common in the care of health clinic patients.

In discussing telehealth transition in the clinics, provider leadership noted the following:

1.  Additional office staff were required to rapidly enroll patients in Epic, so that telehealth visits could be performed.

2.  Additional training for office staff was required specifically to schedule and manage telehealth appointments.

3.  Determination of which visits could be performed via telehealth versus which mandated in-person visits was initially a time-intensive process.

4.  Additional staff supervisors were required to manage these processes.

5.  Provider workflow and scheduling had to be reorganized to facilitate telehealth visits.

6.  Phone calls and text reminders within 48 hours of appointment time improved patient attendance for telehealth and in-person visits.

7.  Patient outreach and phone calls to perform troubleshooting enhanced telehealth use.

Significant barriers to telehealth and in-person visits included the following:

1.  Many patients were fearful of COVID-19 infection and delayed or abstained from seeking medical attention.

2.  The Epic MyChart interface did not include an option with Spanish instructions making enrollment more challenging for many patients.

Key features that facilitated successful use and transition to telehealth included the following:

1.  A telehealth-enabled EMR that allowed simultaneous review of records and documentation during the visit.

2.  Continuous IT assistance for providers and staff.

3.  Holding regular meetings with a dedicated telehealth leadership team to review progress, troubleshoot problem areas, and review patient enrollment and scheduling.

Discussion
==========

In this study of transition to prenatal telehealth during the COVID-19 pandemic in New York City, we were able to perform a large proportion of visits virtually. Uptake was rapid with approximately half of visits across sites conducted virtually by the week of March 30 to April 3, 2020. While providers generally had positive attitudes toward telehealth visits, a key finding from this analysis is that the transition to virtual prenatal care was more challenging for patients with Medicaid insurance receiving care at health clinics than for women with commercial insurance in generalist and maternal fetal medicine faculty practices. Factors related to differential care attendance included (1) operational considerations such as requiring increased staffing in clinics and (2) patient factors related to technological proficiency, language barriers, Wi-Fi and data access, child care, and fear of infection.

These findings have several implications for clinical management. First, because patients with Medicaid insurance may face additional barriers to implement telehealth, it may be reasonable to create in advance a framework for patient enrollment and operational changes prior to widespread telehealth adoption ( [Table 3](#TB200363-3){ref-type="table"} ). While other clinical operations may be curtailed on a hospital or system level in the setting of the COVID-19 pandemic, obstetrical services including prenatal care must be continued to be offered at full capacity. Therefore, additional IT and administrative resources are likely required to optimize telehealth transition. This study found that many operational issues were able to be addressed in a relatively short time period in the setting of a major public health emergency; with more lead time and advanced planning, telehealth transition may be even less disruptive for patients with public insurance. Second, that a large proportion of patients missed in-person visits during the third week of the analysis (likely due to factors such as child care responsibilities and fear of infection) supports telehealth as a critical resource in the setting of the pandemic. While comparative effectiveness research on telehealth is limited outside the pandemic, [@JR200363-9] [@JR200363-10] current conditions support that there is a substantial benefit to telehealth use during the pandemic and beyond. Third, there was limited evidence of barriers to offering care from the standpoint of provider workflow. Accessing technology, performing visits, documentation, and follow-up using the telehealth EMR were all viewed favorably by providers. These findings support that appropriate telehealth can be operationalized for providers quickly. Finally, the low rate of missed appointments for private insurance patients supports that this population faces fewer challenges with accessing telehealth and may require less support.

###### Recommendations regarding resources and management for telehealth implementation in the setting of the COVID-19 pandemic

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Provider electronic medical record telehealth training resources\
   • Online tutorials\
   • Printed work-flow guidelines\
   • In-person electronic medical record support staff

  2\. Patient educational and administrative support\
   • Ensure up-to-date contact information for all patients\
   • Develop educational materials and instructions for patients in multiple languages\
   • Schedule patients in-person visit or remotely to set up telehealth technology prior to their first visit\
   • Facilitate access to required home monitoring devices including a blood pressure cuffs, pulse oximetry, and scales

  3\. Clinical leadership team\
   • Review scheduled visits to decide whether telehealth may be appropriate\
   • Develop a visit-type coding system to communicate with administrative information technology staff the needs of each patient for appropriate visit booking

  4\. Administrative leadership team\
   • Ensure all patients are scheduled appropriately based on needs and visit type (new prenatal visit, follow-up prenatal visit, postpartum, preconception counseling, prenatal consultation)\
   • Ensure patients have set up software prior to telehealth visits\
   • Instruct patients to call if they have COVID-19 symptoms prior to in-person visits

  5\. Departmental administrative resources\
   • Standardized billing approaches for telehealth visits\
   • Formalized guidelines for telehealth versus in-person prenatal visits\
   • Formalized guidelines for prenatal ultrasound and fetal testing
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviation: COVID-19. Novel coronavirus disease 2019.

Limitations and Strengths
=========================

There are some limitations in interpreting the findings of this study. First, we did not directly survey or interview patients, and inferences related to barriers to care are made indirectly based on provider responses and analyzing appointment data. We are not able to empirically determine to what degree appointments were not attended because of child care responsibilities, limited access to devices and connectivity, challenges with using telehealth software leading to conversion to voice only visits, administrative and scheduling issues, financial repercussions of the pandemic, or general fear and anxiety of attending appointments. Financial repercussions of the COVID-19 pandemic may have also been a factor in both attending in-person and virtual visits by decreasing access to Wi-Fi and data plans for mobile devices. Second, we do not have information regarding how patients perceived telehealth prenatal care, and it is possible that they could view it differently than providers. Third, all of the findings related to this analysis are dependent on use of one EMR platform. It is possible that provider satisfaction and operational issues could be better or worse with different EMR products. Strengths of this study include that the analysis was based on real-time implementation of widespread telehealth in the setting of a major public health crisis, that we demonstrated usability and satisfaction among providers, and that major operational challenges and barriers for health clinic patients were able to be significantly addressed in real-time to improve patient access.

Conclusion
==========

In conclusion, rapid transition to telehealth for prenatal care was feasible and associated with provider satisfaction in this study. Significant barriers to telehealth may be present for patients with Medicaid insurance that may require additional support to resolve.
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